Comparative Benchmarking
In the context of the broader market, INDP competes directly with industry leaders such as XRTX and XBIO. With a market capitalization of $4.04M, it holds a significant position in the sector. When comparing efficiency, INDP's gross margin of N/A stands against XRTX's N/A and XBIO's 100.00%. Such benchmarking helps identify whether Indaptus Therapeutics Inc is trading at a premium or discount relative to its financial performance.
